Deep learning-enhanced paper-based vertical flow assay for high-sensitivity troponin detection using nanoparticle amplification
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Preprint |
| Publié: |
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866917794781593600 |
|---|---|
| author | Han, Gyeo-Re Goncharov, Artem Eryilmaz, Merve Joung, Hyou-Arm Ghosh, Rajesh Yim, Geon Chang, Nicole Kim, Minsoo Ngo, Kevin Veszpremi, Marcell Liao, Kun Garner, Omai B. Di Carlo, Dino Ozcan, Aydogan |
| author_facet | Han, Gyeo-Re Goncharov, Artem Eryilmaz, Merve Joung, Hyou-Arm Ghosh, Rajesh Yim, Geon Chang, Nicole Kim, Minsoo Ngo, Kevin Veszpremi, Marcell Liao, Kun Garner, Omai B. Di Carlo, Dino Ozcan, Aydogan |
| contents | Successful integration of point-of-care testing (POCT) into clinical settings requires improved assay sensitivity and precision to match laboratory standards. Here, we show how innovations in amplified biosensing, imaging, and data processing, coupled with deep learning, can help improve POCT. To demonstrate the performance of our approach, we present a rapid and cost-effective paper-based high-sensitivity vertical flow assay (hs-VFA) for quantitative measurement of cardiac troponin I (cTnI), a biomarker widely used for measuring acute cardiac damage and assessing cardiovascular risk. The hs-VFA includes a colorimetric paper-based sensor, a portable reader with time-lapse imaging, and computational algorithms for digital assay validation and outlier detection. Operating at the level of a rapid at-home test, the hs-VFA enabled the accurate quantification of cTnI using 50 uL of serum within 15 min per test and achieved a detection limit of 0.2 pg/mL, enabled by gold ion amplification chemistry and time-lapse imaging. It also achieved high precision with a coefficient of variation of < 7% and a very large dynamic range, covering cTnI concentrations over six orders of magnitude, up to 100 ng/mL, satisfying clinical requirements. In blinded testing, this computational hs-VFA platform accurately quantified cTnI levels in patient samples and showed a strong correlation with the ground truth values obtained by a benchtop clinical analyzer. This nanoparticle amplification-based computational hs-VFA platform can democratize access to high-sensitivity point-of-care diagnostics and provide a cost-effective alternative to laboratory-based biomarker testing. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2402_11195 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | Deep learning-enhanced paper-based vertical flow assay for high-sensitivity troponin detection using nanoparticle amplification Han, Gyeo-Re Goncharov, Artem Eryilmaz, Merve Joung, Hyou-Arm Ghosh, Rajesh Yim, Geon Chang, Nicole Kim, Minsoo Ngo, Kevin Veszpremi, Marcell Liao, Kun Garner, Omai B. Di Carlo, Dino Ozcan, Aydogan Medical Physics Applied Physics Biological Physics Successful integration of point-of-care testing (POCT) into clinical settings requires improved assay sensitivity and precision to match laboratory standards. Here, we show how innovations in amplified biosensing, imaging, and data processing, coupled with deep learning, can help improve POCT. To demonstrate the performance of our approach, we present a rapid and cost-effective paper-based high-sensitivity vertical flow assay (hs-VFA) for quantitative measurement of cardiac troponin I (cTnI), a biomarker widely used for measuring acute cardiac damage and assessing cardiovascular risk. The hs-VFA includes a colorimetric paper-based sensor, a portable reader with time-lapse imaging, and computational algorithms for digital assay validation and outlier detection. Operating at the level of a rapid at-home test, the hs-VFA enabled the accurate quantification of cTnI using 50 uL of serum within 15 min per test and achieved a detection limit of 0.2 pg/mL, enabled by gold ion amplification chemistry and time-lapse imaging. It also achieved high precision with a coefficient of variation of < 7% and a very large dynamic range, covering cTnI concentrations over six orders of magnitude, up to 100 ng/mL, satisfying clinical requirements. In blinded testing, this computational hs-VFA platform accurately quantified cTnI levels in patient samples and showed a strong correlation with the ground truth values obtained by a benchtop clinical analyzer. This nanoparticle amplification-based computational hs-VFA platform can democratize access to high-sensitivity point-of-care diagnostics and provide a cost-effective alternative to laboratory-based biomarker testing. |
| title | Deep learning-enhanced paper-based vertical flow assay for high-sensitivity troponin detection using nanoparticle amplification |
| topic | Medical Physics Applied Physics Biological Physics |
| url | https://arxiv.org/abs/2402.11195 |